PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
59.52
ESG score 90-95% of MDGL's 64.08. Bill Ackman would demand clear ESG improvement catalysts.
60.80
Similar environmental score to MDGL's 63.88. Bruce Berkowitz would investigate if industry environmental norms adequately address climate transition risks.
59.46
Similar social score to MDGL's 60.13. Bruce Berkowitz would investigate if industry social norms adequately address stakeholder expectations.
58.31
Governance score 80-90% of MDGL's 68.24. Walter Schloss would scrutinize management accountability and board independence.